Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and-9: Implications for chemotaxis

被引:34
|
作者
Denney, Helen [1 ]
Clench, Malcolm R. [1 ]
Woodroofe, M. Nicola [1 ]
机构
[1] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England
关键词
Chemokines; Processing; Chemotaxis; CCL2; CXCL10; MMP-2; MMP-9; Matrix metalloproteinase; Multiple sclerosis; Cell migration; GELATINASE-B; POSTTRANSLATIONAL MODIFICATIONS; RECEPTOR; EXPRESSION; IP-10; CXCR3; ANTAGONISTS; ENZYME; RANTES; MCP-2;
D O I
10.1016/j.bbrc.2009.02.164
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteolytic processing of chemokines is a complex process that can result in dramatic effects on their chemotactic activity. Results from gel electrophoresis and mass spectrometry using recombinant CCL2 and CXCL10, incubated with either MMP-2 or -9, indicate that both chemokines are cleaved by the enzymes. N-terminal truncation of four amino acids from CCL2. and four or five residues from CXCL10 occurred, but removal of four residues from the C-terminus of CXCL10 was also observed with both MMPs. The speed of the reaction was chemokine-dependent, with N-terminal processing of CCL2 being complete within 3 h, whereas activity of the MMPs on CXCL10 remained incomplete at 48 h. The effect on the chemotactic potential of N-terminal truncation of CCL2 by MMPs-2 and -9 was investigated using in vitro migration assays. Monocytic cells exhibited a 2-fold reduction in migration to MMP-cleaved CCL2 variants, compared to intact CCL2. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:341 / 347
页数:7
相关论文
共 50 条
  • [1] CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis -: a longitudinal study
    Antonelli, A.
    Ferri, C.
    Fallahi, P.
    Ferrari, S. M.
    Giuggioli, D.
    Colaci, M.
    Manfredi, A.
    Frascerra, S.
    Franzoni, F.
    Galetta, F.
    Ferrannini, E.
    RHEUMATOLOGY, 2008, 47 (01) : 45 - 49
  • [2] Chemokines in Kawasaki disease: Measurement of CCL2, CCL22 and CXCL10
    Shikishima, Y
    Saeki, T
    Matsuura, N
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2003, 21 (03): : 139 - 143
  • [3] Serum activity of matrix metalloproteinases-2 and-9
    G. M. Soboleva
    A. V. Shurshalina
    G. T. Sukhikh
    Bulletin of Experimental Biology and Medicine, 2006, 141 : 247 - 249
  • [4] Serum activity of matrix metalloproteinases-2 and-9
    Soboleva, GM
    Shurshalina, AV
    Sukhikh, GT
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 141 (02) : 247 - 249
  • [5] Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis
    Sorensen, TL
    Sellebjerg, F
    Jensen, CV
    Strieter, RM
    Ransohoff, RM
    EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (06) : 665 - 672
  • [6] Activity of matrix metalloproteinases-2 and-9 in advanced laryngeal cancer
    Bogusiewicz, M
    Stryjecka-Zimmer, M
    Szymanski, M
    Rechberger, T
    Golabek, W
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2003, 128 (01) : 132 - 136
  • [7] Albumin modulates the production of matrix metalloproteinases-2 and-9 in podocytes
    Fang, Zhan
    He, Fangfang
    Chen, Shan
    Sun, Xifeng
    Zhu, Zhonghua
    Zhang, Chun
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (06) : 710 - 714
  • [8] Matrix metalloproteinases-2 and-9 are secreted from human fibroblasts
    Kobayashi, T
    Hattori, S
    Shinkai, H
    ACTA DERMATO-VENEREOLOGICA, 2003, 83 (02) : 105 - 107
  • [9] Production of matrix metalloproteinases-2 and-9 by cultured uveal melanocytes
    Hu, DN
    Yang, F
    Wu, D
    Shen, X
    McCormick, SA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [10] Uveal melanocytes produce matrix metalloproteinases-2 and-9 in vitro
    Chu, SC
    Hu, DN
    Yang, SF
    Yang, PY
    Hsieh, YS
    Huang, SM
    Yu, G
    McCormick, SA
    PIGMENT CELL RESEARCH, 2004, 17 (06): : 636 - 642